CCAAT/enhancer binding protein α regulates p21 protein and hepatocyte proliferation in newborn mice

Molecular and Cellular Biology

Volumn 17, Issue 12, 1997, Pages 7353-7361

  Timchenko, Nikolai A ^a   Harris, Thurl E ^a   Wilde, Margaret ^a   Bilyeu, Timothy A ^a   Burgess Beusse, Bonnie L ^a   Finegold, Milton J ^a   Darlington, Gretchen J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; TRANSCRIPTION FACTOR;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; LIVER CELL; LIVER REGENERATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALIA; MAMMALIA;

EID: 0030658965     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.12.7353     Document Type: Article

References (37)

1. Albrecht, J. Personal communication.
2. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
3. Descombes, P., and U. Schibler. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569-579.
4. Diehl, A. M., D. C. Johns, S. Yang, H. Lin, M. Yin, L. A. Matelist, and J. H. Lawrence. 1996. Adenovirus-mediated transfer of CCAAT/enhancer-binding protein-alpha identifies a dominant antiproliferative role for this isoform in hepatocytes. J. Biol. Chem. 271:7343-7350.
5. Diehl, A. M., and S. Q. Yang. 1993. Regenerative changes in C/EBPα and C/EBPβ expression modulate binding to the C/EBP site in the c-fos promoter. Hepatology 19:447-456.
6. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzier, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
7. Fausto, N., and E. M. Webber. 1994. Liver regeneration, p. 1059-1084. In I. M. Arias, J. L. Boyer, N. Fausto, W. B. Jakoby, D. Schacter, and D. A. Schafritz (ed.), The liver: biology and pathobiology, 3rd ed. Raven Press, New York, N.Y.
8. Kip1-deficient mice. Cell 85:733-744.
9. Flodby, P., P. Antonson, C. Barlow, A. Blanck, I. Porsh-Hallstrom, and K. G. Xanthopoulos. 1993. Differential patterns of expression of three C/EBP isoforms, HNF-1, and HNF-4 after partial hepatectomy in rats. Exp. Cell Res. 208:248-256.
10. Flodby, P., C. Barlow, H. Kylefjord, L. Ahrlund-Richter, and K. G. Xanthopoulos. 1996. Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein α. J. Biol. Chem. 271: 24753-24760.
11. Flodby, P., D. Liao, A. Blanck, K. G. H. Xanthopoulos, and I. P. Hällström. 1995. Expression of the liver-enriched transcription factors C/EBPα, C/ EBPβ, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver. Mol. Carcinog. 12:103-109.
12. Freytag, S. O., and T. J. Geddes. 1992. Reciprocal regulation of adipogenesis by Myc and C/EBPα. Science 256:379-382.
13. Freytag, S. O., D. L. Paielli, and J. D. Gilbert. 1994. Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 8:1654-1663.
14. Friedman, A. D., W. H. Landschulz, and S. L. McKnight. 1989. CCAAT/ enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev. 3:1314-1322.
15. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
16. Hendricks-Taylor, L. R., and G. J. Darlington. 1995. Inhibition of cell proliferation by C/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen. Nucleic Acids Res. 23:4726-4733.
17. Juan, T. S., D. R. Wilson, M. D. Wilde, and G. J. Darlington. 1993. Participation of the transcription factor C/EBP delta in the acute phase regulation of the human gene for complement component C3. Proc. Natl. Acad. Sci. USA 90:2584-2588.
18. Kip1. Cell 85:721-732.
19. Landschulz, W. H., P. F. Johnson, E. Y. Adashi, B. J. Graves, and S. L. McKnight. 1988. Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev. 2:786-800.
20. Landschulz, W. H., P. F. Johnson, and S. L. McKnight. 1988. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240:1759-1764.
21. Landschulz, W. H., P. F. Johnson, and S. L. McKnight. 1989. The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. Science 243:1681-1688.
22. Lin, F. T., and M. D. Lane. 1994. CCAAT/enhancer binding protein α is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc. Natl. Acad. Sci. USA 91:8757-8761.
23. Lin, F. T., O. A. MacDougald, A. M. Diehl, and M. D. Lane. 1993. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha messages: transcriptional activator lacking antimitotic activity. Proc. Natl. Acad. Sci. USA 90:9606-9610.
24. Maki, C. G., and P. M. Howley. 1997. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell. Biol. 17:355-363.
25. Mischoulon, D., B. Rana, N. L. R. Bucher, and S. R. Farmer. 1992. Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBPα) gene expression during hepatocyte proliferation in the regenerating liver and in culture. Mol. Cell. Biol. 12:2553-2560.
26. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707-720.
27. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
28. Ossipow, V., P. Descombes, and U. Schibler. 1993. CCAAT/enhancer binding protein mRNA is translated into multiple protein with different transcription activation potentials. Proc. Natl. Acad. Sci. USA 90:8219-8223.
29. 1 cell cycle arrest of minimal-deviation rat hepatoma cells. Mol. Cell. Biol. 16:5288-5301.
30. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
31. 29a. Timchenko, N. Unpublished data.
32. Timchenko, N., D. R. Wilson, L. R. Taylor, A. M. Wilde, S. Abdelsayed, M. Sawadogo, and G. J. Darlington. 1995. Autoregulation of the human C/ EBPα gene by stimulation of upstream stimulatory factor binding. Mol. Cell. Biol. 15:1192-1202.
33. Timchenko, N. A., M. Wilde, M. Nakanishi, J. R. Smith, and G. J. Darlington. 1996. CCAAT/enhancer binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev. 10:804-815.
34. Umek, R. M., A. D. Friedman, and S. L. McKnight. 1991. CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251:288-292.
35. Wang, N. D., M. J. Finegold, A. Bradley, C. N. Ou, S. V. Abdelsayed, M. D. Wilde, L. R. Taylor, D. R. Wilson, and G. J. Darlington. 1995. Impaired energy homeostasis in C/EBP alpha knock-out mice. Science 269:1108-1112.
36. Wu, J., M. Wade, L. Krall, J. Grisham, Y. Xiong, and T. Van Dyke. 1996. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev. 10:245-260.
37. Yeh, W. C., Z. Cao, M. Classon, and S. L. McKnight. 1995. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9:168-181.